Patent · US Expired

Substituted peptide compounds

US4470973A · kind A · utility

58Cited by
22References
53Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 2, 1983
Grant dateSep 11, 1984
Priority date
Expiry dateJun 2, 2003

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/80
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Substituted peptide compounds of the formula ##STR1## are disclosed. These compounds are useful as hypotensive agents due to their angiotensin converting enzyme inhibition activity and depending upon the definition of X may also be useful as analgesics due to their enkephalinase inhibition activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.